Initial sirolimus dosage recommendations for pediatric patients with PIK3CD mutation-related immunodeficiency disease

Sirolimus is used to treat pediatric patients with PIK3CD mutation-related immunodeficiency disease. However, the initial dosages of sirolimus remain undecided. The present study aims to explore initial dosages in pediatric patients with PIK3CD mutation-related immunodeficiency disease. Pediatric pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xiao, Wang, Jinglin, Lan, Jianger, Ge, Xilin, Xu, Hong, Zhang, Yu, Li, Zhiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515533/
https://www.ncbi.nlm.nih.gov/pubmed/36188573
http://dx.doi.org/10.3389/fphar.2022.919487

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515533/
https://www.ncbi.nlm.nih.gov/pubmed/36188573
http://dx.doi.org/10.3389/fphar.2022.919487

Ejemplares similares